iF Design - PortraiTME

PortraiTME epitomizes the fusion of AI and medical research in a package designed for ultimate user engagement. The interface elegantly simplifies complex tumor micro-environment analysis, demystifying science without diluting it. The user experience is like a scalpel—precise, effective, and specialized—making intricate medical data accessible and understandable. We marry spatial transcriptomics and deep learning with a human-centered design ethos. In doing so, PortraiTME transcends being just another AI tool; it becomes an essential experience, revolutionizing diagnosis and treatment planning. Experience AI, humanized, with PortraiTME.

Hongyoon Choi | Innovators Under 35

innovatorsunder35

Our annual list of the young dreamers, tinkerers, and innovators that are creating technology’s future.

Beyond the Main Stage: A Showcase of the Next Wave of Korean Biotech Innovation at JPM Week 2026

geneonline

January 15, 2026

As the global biomedical industry converges in San Francisco for the 44th Annual J.P. Morgan Healthcare Conference (JPM 2026), South Korea has firmly established itself as a dominant force in the Asia-Pacific biotech landscape. While industry giants like Samsung Biologics and Celltrion commanded attention on the Main Track at the Westin St. Francis, a dynamic wave of innovation was unfolding just blocks away.

Artificial Intelligence in Radiation Protection of Patients: Diagnostic and therapeutic nuclear medicine

IAEA

November 25, 2025

As artificial intelligence (AI) continues to revolutionize healthcare, its potential to enhance patient safety and improve radiation protection practices is becoming increasingly evident. This webinar series aims to explore how AI-driven tools and technologies can support and advance the safe and effective use of radiation in medical settings. Tailored for a broad audience of healthcare professionals — including clinicians, radiologists, radiation oncologists, nuclear medicine physicians, technologists, medical physicists, hospital administrators and regulators — each session will feature expert led presentations followed by a live discussion. Participants can deepen their understanding and exchange ideas with leading professionals in the field.

Portrai, BL Melanis win Amgen–KHIDI Golden Ticket for 2025 biotech innovation

Korea Biomedical Review

November 13, 2025

Amgen Korea and the Korea Health Industry Development Institute (KHIDI) on Thursday announced two biotech start-ups — Portrai and BL Melanis — as the winners of the 2025 Golden Ticket, a global open innovation initiative by Amgen to identify promising biotech ventures and support their global growth. 출처 : KBR(https://www.koreabiomed.com)

Celltrion signs joint research deal with Portrai to discover cancer drug targets

ChosunBiz

October 29, 2025

Celltrion said on the 29th that it signed a joint research agreement with domestic artificial intelligence (AI) new drug developer Portrai to search for new drug targets using spatial transcriptomics and AI technology.

[Diplomacy Journal] Korea Startup Forum and the British Embassy jointly hold IR Day

Diplomacy Journal

July 17, 2025

The Korea Startup Forum (KOSFO) announced on July 17 that it successfully held the “KSF IR Day,” a practical IR program supporting promising domestic deep tech startup

Pick of the posters: AACR 2024

BioTechniques

April 25, 2024

At AACR 2024, we explored the poster hall to pick out the posters that would interest the BioTechniques reader and those we found delivered the most interesting or surprising findings. Get our selections below and let us know your thoughts on our Pick of the posters. Contents: pyVIPER: a fast and scalable toolkit for the […]

South Korean Biotech Company Portrai Inc. Adopts Infortrend Storage to Enable AI Data Analysis for Pharmaceutical Drug Development

PR Newswire

September 12, 2023

/PRNewswire/ -- Infortrend® Technology, Inc. (TWSE: 2495), the industry-leading enterprise storage manufacturer, provided South Korean biotech company Portrai...

Why I chose spatial: New pathways into clinical translational research - 10x Genomics

10x Genomics

August 16, 2022

Why did Choi Hongyoon, MD, PhD, Assistant Professor at Seoul National University Hospital, choose spatial? Learn more in our blog.